These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 16720367)

  • 1. Matrix metalloproteinases and their inhibitors in bone: an overview of regulation and functions.
    Varghese S
    Front Biosci; 2006 Sep; 11():2949-66. PubMed ID: 16720367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel therapeutic approaches targeting matrix metalloproteinases in cardiovascular disease.
    Briasoulis A; Tousoulis D; Papageorgiou N; Kampoli AM; Androulakis E; Antoniades C; Tsiamis E; Latsios G; Stefanadis C
    Curr Top Med Chem; 2012; 12(10):1214-21. PubMed ID: 22519451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of IL-1alpha on the expression of matrix metalloproteinases, plasminogen activators, and their inhibitors in osteoblastic ROS 17/2.8 cells.
    Fujisaki K; Tanabe N; Suzuki N; Mitsui N; Oka H; Ito K; Maeno M
    Life Sci; 2006 Mar; 78(17):1975-82. PubMed ID: 16313928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives.
    Beaudeux JL; Giral P; Bruckert E; Foglietti MJ; Chapman MJ
    Clin Chem Lab Med; 2004 Feb; 42(2):121-31. PubMed ID: 15061349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Matrix Metalloproteinases in Degenerative Kidney Disorders.
    Narula S; Tandon C; Tandon S
    Curr Med Chem; 2018; 25(15):1805-1816. PubMed ID: 29210632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone tissue remodeling and development: focus on matrix metalloproteinase functions.
    Paiva KB; Granjeiro JM
    Arch Biochem Biophys; 2014 Nov; 561():74-87. PubMed ID: 25157440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical and Biological Attributes of Matrix Metalloproteinases.
    Cui N; Hu M; Khalil RA
    Prog Mol Biol Transl Sci; 2017; 147():1-73. PubMed ID: 28413025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix Metalloproteinases in Bone Resorption, Remodeling, and Repair.
    Paiva KBS; Granjeiro JM
    Prog Mol Biol Transl Sci; 2017; 148():203-303. PubMed ID: 28662823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.
    Wang X; Khalil RA
    Adv Pharmacol; 2018; 81():241-330. PubMed ID: 29310800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoblasts and osteocytes express MMP2 and -8 and TIMP1, -2, and -3 along with extracellular matrix molecules during appositional bone formation.
    Hatori K; Sasano Y; Takahashi I; Kamakura S; Kagayama M; Sasaki K
    Anat Rec A Discov Mol Cell Evol Biol; 2004 Apr; 277(2):262-71. PubMed ID: 15052653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease.
    Raffetto JD; Khalil RA
    Biochem Pharmacol; 2008 Jan; 75(2):346-59. PubMed ID: 17678629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TIMPs as multifacial proteins.
    Lambert E; Dassé E; Haye B; Petitfrère E
    Crit Rev Oncol Hematol; 2004 Mar; 49(3):187-98. PubMed ID: 15036259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs.
    Jabłońska-Trypuć A; Matejczyk M; Rosochacki S
    J Enzyme Inhib Med Chem; 2016; 31(sup1):177-183. PubMed ID: 27028474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinase dependent and independent collagen degradation.
    Song F; Wisithphrom K; Zhou J; Windsor LJ
    Front Biosci; 2006 Sep; 11():3100-20. PubMed ID: 16720379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinases: their biological functions and clinical implications.
    Hijova E
    Bratisl Lek Listy; 2005; 106(3):127-32. PubMed ID: 16026148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Updating the role of matrix metalloproteinases in mineralized tissue and related diseases.
    Tokuhara CK; Santesso MR; Oliveira GSN; Ventura TMDS; Doyama JT; Zambuzzi WF; Oliveira RC
    J Appl Oral Sci; 2019 Sep; 27():e20180596. PubMed ID: 31508793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of extracellular matrix molecules, MMPs and TIMPs in alveolar bone, cementum and periodontal ligaments during rat tooth eruption.
    Maruya Y; Sasano Y; Takahashi I; Kagayama M; Mayanagi H
    J Electron Microsc (Tokyo); 2003; 52(6):593-604. PubMed ID: 14756248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinases and periodontal diseases.
    Sapna G; Gokul S; Bagri-Manjrekar K
    Oral Dis; 2014 Sep; 20(6):538-50. PubMed ID: 23849049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinases induce extracellular matrix degradation through various pathways to alleviate hepatic fibrosis.
    Shan L; Wang F; Zhai D; Meng X; Liu J; Lv X
    Biomed Pharmacother; 2023 May; 161():114472. PubMed ID: 37002573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory mechanisms in atherosclerosis: the impact of matrix metalloproteinases.
    Siasos G; Tousoulis D; Kioufis S; Oikonomou E; Siasou Z; Limperi M; Papavassiliou AG; Stefanadis C
    Curr Top Med Chem; 2012; 12(10):1132-48. PubMed ID: 22519444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.